DWN12088

· Daewoong Pharmaceutical Co. LTD.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DWN12088, covering 2025-08-05 to 2025-08-05. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF [Phase 2]